Reference : Vers une tritherapie orale dans le traitement pharmacologique du diabete de type 2?
Scientific journals : Article
Human health sciences : Pharmacy, pharmacology & toxicology
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/10242
Vers une tritherapie orale dans le traitement pharmacologique du diabete de type 2?
French
[en] Towards a tripple oral therapy in the pharmacological treatment of type 2 diabetes?
Scheen, André mailto [Université de Liège - ULg > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
2005
Revue Médicale de Liège
60
5-6
Le diabète sucré dans tous ses états
414-8
Yes (verified by ORBi)
0370-629X
Belgium
[en] Blood Glucose/metabolism ; Cardiovascular Diseases/etiology/prevention & control ; Diabetes Mellitus, Type 2/drug therapy ; Drug Therapy, Combination ; Humans ; Hypoglycemic Agents/therapeutic use ; Metformin/therapeutic use ; Risk Factors ; Thiazolidinediones/therapeutic use
[en] Type 2 diabetes is a complex disease combining several disturbances in various organs, especially a defect of insulin secretion by the pancreas, an increased production of glucose by the liver and a reduced insulin-mediated glucose uptake by the skeletal muscle. Each of these abnormalities can be, at least partially, reversed by a specific pharmacological approach, an agent promoting insulin secretion (sulphonylurea, glinide), metformin and a thiazolidinedione (glitazone), respectively. A triple oral therapy with "sulphonylurea (glinide)--metformin--glitazone", targeting simultaneously the three main metabolic abnormalities of type 2 diabetes, deserves special attention. Promising results have been observed in recent clinical trials as far as blood glucose control and some other cardiovascular risk factors are concerned. The precise place of such oral triple therapy remains to be specified, at a late stage to delay the shift to insulin or earlier in the natural history of the disease, to avoid the decline of the number and/or function of beta cells and the resulting metabolic deterioration.
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/10242
http://www.rmlg.ulg.ac.be

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
20050506_27.pdfNo commentaryPublisher postprint571.41 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.